Although, an ambiguity is seen, in the way AT2 receptor is involved in the regulation of miRNAs, a steady and constant regulatory pattern was observed in AT1 mediated miRNA regulation, further confirming the suitability of AT1 receptor as a potential therapeutic target of RAS mediated metabolic disorders. The gene discussed is AGTR2; the disease is metabolic disease.